# MSCI Inc. (MSCI) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Financial Services / Capital Markets. Price $639.78, market value $46.5 billion.

## Valuation
- **P/E (trailing): 33.8×** (5-yr avg 44.9×, 3-yr avg 38.7×). MSCI Inc. trades at 33.8× trailing earnings, well below its own five-year average of 44.9×: cheap by its own standards. The Financial Services median in the September 2026 study was 13.1×. Forward P/E is 28.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 2.44**. A PEG of 2.44 means the P/E is high relative to expected earnings growth; the price already assumes a lot.
- **Price / sales: 13.6×**. Each dollar of revenue is priced at 13.6×, a level that requires very high margins or very fast growth to justify.
- **EV / EBITDA: 27.0×**. Enterprise value is 27.0× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 3.4%** (5-yr avg 2.9%). Free cash flow equals 3.4% of the market value, in line with its five-year average of 2.9%.
- **Earnings yield: 3.0%**. The inverse of the P/E: 3.0% of the price is earned each year.

## Profitability
- **Operating margin: 55.7%**. 55.7% of revenue is left after running the business, an exceptional level.
- **Net margin: 38.4%**. 38.4% of each dollar of sales reaches the bottom line.
- **Return on equity: -45.3%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 49.8%**. Return on all capital, debt included, is 49.8%: comfortably above what that capital costs.
- **Return on assets: 24.3%**. Each dollar of assets produces 24.3% of profit; low single digits are normal for banks and insurers.

## Growth
- **Revenue growth (1 yr): 9.7%** (3-yr 11.7%/yr, 5-yr 13.1%/yr). Revenue grew 9.7% over the last year, against 13.1% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 11.7%** (3-yr 13.5%/yr, 5-yr 17.1%/yr). Earnings per share rose 11.7%, roughly in step with revenue.
- **Free-cash-flow growth (3 yr): 12.7%/yr**. Free cash flow has compounded at 12.7% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.
- **Cash and short-term investments: $515 million**. Leverage ratios are shown differently for banks and insurers, whose balance sheets are built on deposits and reserves; use return on equity and the regulatory capital in the filings instead.

## Dividends
- **Dividend yield: 1.28%** ($7.95 per share, trailing). MSCI Inc. yields 1.28%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 46%** (37% of free cash flow). 46% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 12**. 12 straight years of increases, a record that survived at least one recession.
- **Dividend growth (5 yr): 19.8%/yr** (1-yr 12.5%). The dividend has compounded at 19.8% a year over five years, doubling roughly every 4 years at that pace.

## Analyst view
- **Analyst consensus: strong_buy** (17 analysts). 17 analysts cover MSCI Inc.; the consensus is strong_buy, with an average price target of $684.12 (+7% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 9.4%** (YTD 11.9%, 3-mo 10.9%). The shares are up 9.4% over twelve months including dividends.
- **From 52-week high: -0.8%** (27.7% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 72**. An RSI of 72 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 0.32** (volatility 29%). Beta of 0.32 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MSCI · Page: https://foliofundamentals.com/stocks/msci

Not investment advice.
